Skip to main content

Commodore Capital LP

SEC CIK
0001831942
Latest filing
Aug 14, 2026

CTMX holding history

CytomX Therapeutics, Inc. in every 13F filed by Commodore Capital LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CTMX overviewAll 13F holders of CTMXFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
3
Since Q2 2025
Holdings of CTMX by Commodore Capital LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−7,692,300−100.0%Sold outHolders
Q4 20257,692,300$32.8M2.2%00.0%UnchangedHolders
Q3 20257,692,300$24.5M1.2%00.0%UnchangedHolders
Q2 20257,692,300$17.5M1.2%+7,692,300NewHolders